Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Exploring the economy-wide effects of agriculture on air quality and health: Evidence from Europe.

Giannakis E, Kushta J, Giannadaki D, Georgiou GK, Bruggeman A, Lelieveld J.

Sci Total Environ. 2019 Jan 31;663:889-900. doi: 10.1016/j.scitotenv.2019.01.410. [Epub ahead of print]

PMID:
30738268
2.

Estimating health and economic benefits of reductions in air pollution from agriculture.

Giannadaki D, Giannakis E, Pozzer A, Lelieveld J.

Sci Total Environ. 2018 May 1;622-623:1304-1316. doi: 10.1016/j.scitotenv.2017.12.064. Epub 2017 Dec 13.

PMID:
29890597
3.

Aberrant protein expression in plasma and kidney tissue during experimental obstructive nephropathy.

Giannakis E, Samuel CS, Hewitson TD, Boon WM, Macris M, Reeve S, Lawrence J, Ian Smith A, Tregear GW, Wade JD.

Proteomics Clin Appl. 2009 Oct;3(10):1211-24. doi: 10.1002/prca.200900021. Epub 2009 Aug 4.

PMID:
21136945
4.

A central role for venom in predation by Varanus komodoensis (Komodo Dragon) and the extinct giant Varanus (Megalania) priscus.

Fry BG, Wroe S, Teeuwisse W, van Osch MJ, Moreno K, Ingle J, McHenry C, Ferrara T, Clausen P, Scheib H, Winter KL, Greisman L, Roelants K, van der Weerd L, Clemente CJ, Giannakis E, Hodgson WC, Luz S, Martelli P, Krishnasamy K, Kochva E, Kwok HF, Scanlon D, Karas J, Citron DM, Goldstein EJ, McNaughtan JE, Norman JA.

Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):8969-74. doi: 10.1073/pnas.0810883106. Epub 2009 May 18.

5.

Evaluation of relaxin's antifibrotic action by SELDI-TOF mass spectrometry-based profiling of relaxin knockout mice, a model of progressive fibrosis.

Giannakis E, Macris M, Chan L, Tregear GW, Samuel CS, Wade JD.

Ann N Y Acad Sci. 2009 Apr;1160:350-2. doi: 10.1111/j.1749-6632.2009.03957.x.

PMID:
19416218
6.

SELDI-TOF mass spectrometry-based protein profiling of kidney tissue.

Giannakis E, Samuel CS, Boon WM, Macris M, Hewitson TD, Wade JD.

Methods Mol Biol. 2009;466:237-49. doi: 10.1007/978-1-59745-352-3_17.

PMID:
19148606
7.

Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity.

Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, Masters CL, Cappai R, Wade JD, Barnham KJ.

J Neurosci. 2008 Nov 12;28(46):11950-8. doi: 10.1523/JNEUROSCI.3916-08.2008.

8.

Analysis of Abeta interactions using ProteinChip technology.

Giannakis E, Hung LW, Camacaro KP, Smith DP, Barnham KJ, Wade JD.

Methods Mol Biol. 2008;494:71-86. doi: 10.1007/978-1-59745-419-3_5.

PMID:
18726569
9.

Dimeric structures of alpha-synuclein bind preferentially to lipid membranes.

Giannakis E, PacĂ­fico J, Smith DP, Hung LW, Masters CL, Cappai R, Wade JD, Barnham KJ.

Biochim Biophys Acta. 2008 Apr;1778(4):1112-9. doi: 10.1016/j.bbamem.2008.01.012. Epub 2008 Jan 26.

10.

Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.

Bozinovski S, Hutchinson A, Thompson M, Macgregor L, Black J, Giannakis E, Karlsson AS, Silvestrini R, Smallwood D, Vlahos R, Irving LB, Anderson GP.

Am J Respir Crit Care Med. 2008 Feb 1;177(3):269-78. Epub 2007 Nov 15.

PMID:
18006888
11.

Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.

Shabanpoor F, Bathgate RA, Hossain MA, Giannakis E, Wade JD, Hughes RA.

J Pept Sci. 2007 Feb;13(2):113-20.

PMID:
17120268
12.

Localization of the third heparin-binding site in the human complement regulator factor H1.

Ormsby RJ, Jokiranta TS, Duthy TG, Griggs KM, Sadlon TA, Giannakis E, Gordon DL.

Mol Immunol. 2006 Apr;43(10):1624-32. Epub 2005 Nov 2.

PMID:
16263173
13.

Studies on soluble ectodomain proteins of relaxin (LGR7) and insulin 3 (LGR8) receptors.

Yan Y, Cai J, Fu P, Layfield S, Ferraro T, Kumagai J, Sudo S, Tang JG, Giannakis E, Tregear GW, Wade JD, Bathgate RA.

Ann N Y Acad Sci. 2005 May;1041:35-9.

PMID:
15956685
14.

A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein.

Giannakis E, Jokiranta TS, Male DA, Ranganathan S, Ormsby RJ, Fischetti VA, Mold C, Gordon DL.

Eur J Immunol. 2003 Apr;33(4):962-9.

15.

The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.

Duthy TG, Ormsby RJ, Giannakis E, Ogunniyi AD, Stroeher UH, Paton JC, Gordon DL.

Infect Immun. 2002 Oct;70(10):5604-11.

16.

Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).

Giannakis E, Jokiranta TS, Ormsby RJ, Duthy TG, Male DA, Christiansen D, Fischetti VA, Bagley C, Loveland BE, Gordon DL.

J Immunol. 2002 May 1;168(9):4585-92.

17.

Multiple ligand binding sites on domain seven of human complement factor H.

Giannakis E, Male DA, Ormsby RJ, Mold C, Jokiranta TS, Ranganathan S, Gordon DL.

Int Immunopharmacol. 2001 Mar;1(3):433-43. Review.

PMID:
11367528
18.

Pinpointing the putative heparin/sialic acid-binding residues in the 'sushi' domain 7 of factor H: a molecular modeling study.

Ranganathan S, Male DA, Ormsby RJ, Giannakis E, Gordon DL.

Pac Symp Biocomput. 2000:155-67.

19.

Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes.

Male DA, Ormsby RJ, Ranganathan S, Giannakis E, Gordon DL.

Mol Immunol. 2000 Jan-Feb;37(1-2):41-52.

PMID:
10781834

Supplemental Content

Loading ...
Support Center